On the medial — inside — aspect of the elbow, we see the diagnosis of ulnar collateral ligament tears in more and more of our throwing athletes, and for these patients an orthobiologic approach is far preferable to surgical reconstruction. We only refer patients for surgery if they have the most severe ligament tears. Most other UCL injuries can be treated nonsurgically with orthobiologics in the office, minimizing rehab time and eliminating surgical risk.
What a UCL injury actually feels like
For most throwers it does not arrive as a dramatic event. It begins as soreness on the inside of the elbow late in an outing, then soreness that starts earlier in the outing, then soreness between outings. Velocity drops a little. Command goes before pain does — the ball starts running arm-side, or the release point moves, and the athlete cannot say why.
A smaller group describes the acute version: a pop or a tearing sensation on a single pitch, immediate pain on the inside of the elbow, and an inability to throw at all afterwards. That presentation is more obvious and, counterintuitively, sometimes carries a better-defined injury than the athlete who has been quietly degrading for two seasons.
Numbness or tingling into the ring and little fingers is common and is not the ligament. The ulnar nerve runs in a groove directly behind the medial epicondyle, and a valgus-stressed elbow irritates it. It needs to be identified separately, because a nerve problem treated as a ligament problem does not improve, and vice versa.
What the UCL does, and why throwing is so hard on it
The ulnar collateral ligament is a short, thick band running from the medial epicondyle of the humerus to the sublime tubercle of the ulna. Its anterior bundle is the primary restraint against valgus stress through most of the elbow's throwing arc. In practical terms: it is the tissue that stops the inside of the elbow from opening up when the arm is laid back and then whipped forward.
The forces generated at the elbow during the late cocking and early acceleration phases of a hard throw approach the failure strength of the ligament itself. That is not an exaggeration and it is the central fact of this injury. A pitcher is not loading the UCL near its limit occasionally — it happens on every competitive pitch. The ligament survives because it repairs between exposures. Injury occurs when the exposures come faster than the repair.
Which is why the classic story is cumulative rather than traumatic, and why the risk factors that matter are the ones governing recovery time: innings, pitch counts, rest days, months per year of throwing, and whether the athlete throws while fatigued.
Not every UCL tear is the same injury
"UCL tear" is a headline, not a diagnosis. Three things separate injuries that carry the same headline into genuinely different clinical problems.
Partial versus complete. A partial tear still has intact fibres bridging the joint and still resisting load. A complete tear has none. Those are different injuries with different treatment and different odds, and the difference is not apparent from symptoms.
Where along the ligament. Tears at the proximal end, nearer the humerus, generally do better without surgery than tears at the distal end near the ulnar insertion. Two athletes with the same grade of partial tear can face materially different prospects depending on location alone.
How much the joint actually opens. This is the functional question and it is the one a static image answers least well. Measured gapping under an applied valgus load, compared against the athlete's uninjured side, describes what the ligament is doing rather than what it looks like.
How the elbow is examined here
The physical examination establishes whether the medial elbow is the source: point tenderness over the ligament rather than over the flexor-pronator origin or the nerve, a valgus stress test, the moving valgus stress test through the throwing arc, and a milking manoeuvre. The ulnar nerve is assessed deliberately and separately. The shoulder, scapula, hip and trunk are examined too, because an elbow that is absorbing load the rest of the chain should have handled will keep failing regardless of what is done to it.
Then dynamic ultrasound, in the same visit, in the same room. This is where the assessment differs most from a standard workup. Ultrasound allows the ligament to be imaged while a valgus load is applied and the elbow is moved — the joint space gapping is measured directly, under stress, and compared with the opposite elbow as the athlete's own control. It also shows the tear itself: partial or complete, proximal or distal, with or without calcification from prior injury.
MRI, and particularly MR arthrography, remains valuable and is ordered when the anatomy needs to be characterised in more detail or when surgical planning depends on it. But an MRI is acquired with the elbow still. The question that decides treatment — how far does this joint open when it is loaded — is a dynamic question, and it is answered with a dynamic test.
Why Tommy John became the default, and why that is changing
Ulnar collateral ligament reconstruction is one of the genuine successes of sports medicine. It took a career-ending injury and made it survivable, and the surgeons who developed and refined it deserve the reputation it has. That success has had a side effect: for a long time, "UCL tear" and "reconstruction" became close to synonymous in the public mind, and in a good deal of clinical practice too.
Two things have shifted. The first is imaging — dynamic ultrasound makes it practical to distinguish partial from complete and proximal from distal in the office, which turns a single diagnosis into a spectrum. The second is that orthobiologic treatment of the partial tears at the milder end of that spectrum has become genuinely effective, particularly with higher platelet doses and accurate ultrasound-guided placement into the tear itself.
The result is not that reconstruction is obsolete. It is that the group of athletes who need it is smaller than the group who are offered it, and that establishing which group a given athlete belongs to is now worth doing carefully.
What the evidence supports, and what it does not
This is a field where the published literature genuinely disagrees with itself, and a patient deciding whether to have an operation deserves to see both halves of that rather than the half that supports whatever the clinic sells.
The supportive data
Podesta and colleagues (American Journal of Sports Medicine, 2013) remains the foundational clinical study and the one that defines the ideal candidate. Thirty-four athletes with partial-thickness UCL tears who had already failed at least two months of conservative care received a single ultrasound-guided PRP injection. Thirty of the thirty-four — 88 percent — returned to their previous level of play, at an average of twelve weeks. Patient-reported scores improved substantially, and, more importantly, so did an objective measure: joint-space opening under valgus stress fell from 7 mm to 2.5 mm. That last figure matters because it is not a questionnaire. It is the ligament doing more of its job than it was doing before.
Fucaloro and colleagues (Arthroscopy, 2025) is the most recent pooled analysis — eight studies, 278 partial-thickness and 44 full-thickness tears. Return-to-sport rates across the whole set ranged widely, from 46 to 100 percent, which is exactly the kind of scatter that makes a systematic review hard to interpret. The useful part is the subgroup analysis: studies using at least twelve weeks of rehabilitation clustered tightly at 87–100 percent return to sport, and studies using leukocyte-poor PRP were similarly more consistent. In other words, the variation is not random. It tracks with how the treatment was actually delivered.
Marcaccio, Arner and Bradley (JAAOS, 2025) reflects where contemporary expert opinion has settled: PRP "may be effective in aiding in the healing process, particularly in proximal and partial-thickness tears." That is a narrow claim, and it names precisely the subgroup this page is about.
The study that argues the other way
The most rigorously controlled data point is not supportive, and it should be stated plainly. Chauhan and colleagues (American Journal of Sports Medicine, 2019) studied a matched cohort of 544 professional baseball players and found that PRP did not improve return to play or ligament survivorship, and was associated with a longer delay in returning to throwing.
That is the best-controlled study in the field and it is negative. Anyone recommending this treatment should be able to say so without flinching.
Why the position statements say "no consensus" — and what that actually means
Both the AMSSM regenerative medicine position statement and the Apostolakos review conclude that no consensus exists on PRP efficacy for UCL injuries. Their stated reason is heterogeneity: variation in PRP preparation, in injection protocol, and in timing.
That reason is correct, and it is the whole argument.
The literature being pooled combines low-dose and high-dose PRP studies — and includes some papers where no dose is mentioned at all. Averaging those together produces exactly the "no consensus" a reader would expect from averaging together interventions that share a name and little else. Our registry data and our review of the high-dose literature show that PRP dose matters for this indication, in the same way it matters for other orthopedic indications. Fucaloro's own subgroup findings point the same direction: when the analysis is narrowed to studies with adequate rehabilitation and a defined PRP composition, the scatter collapses and the results converge.
None of that makes Chauhan wrong. It does mean a negative result from a protocol that is not the protocol being offered here is a reason for care rather than a verdict — and it means the honest question to ask any clinic offering PRP for a UCL tear is not "does PRP work" but "what dose, prepared how, placed where, and with what rehabilitation."
What is not supported, and should not be claimed
That an injection restores a completely torn ligament in an athlete who intends to keep throwing competitively. It does not. Anyone offering an injection for a complete UCL tear in a pitcher who wants to return to the mound is either misreading the imaging or misrepresenting the treatment.
Where bone marrow concentrate fits
We also have the option to use bone marrow aspirate concentrate for more severe or difficult cases. It is not a first-line treatment for a straightforward partial tear, and it is not presented as a stronger version of PRP for every athlete — but where a tear is high-grade, or where a well-executed PRP injection and a proper rehabilitation programme have not produced the expected result, it is a further option short of reconstruction.
The options, all of them
Rest, rehabilitation and mechanics
Non-negotiable and never sufficient on its own for a structural tear, but no treatment on this list works without it. A genuine throwing shutdown, then progressive scapular, rotator cuff, forearm, trunk and hip work, then a graduated interval throwing programme with the throws counted. Mechanics are assessed by people who know what they are looking at. An elbow injured by a kinetic chain that leaks energy will be reinjured by the same chain.
Platelet-rich plasma
Our primary orthobiologic approach for these injuries. High-dose PRP prepared from the athlete's own blood on the day and injected under direct ultrasound guidance into the torn portion of the ligament — not into the general vicinity of the medial elbow. Expect several days of increased soreness afterwards; that is the intended biological response rather than a complication. Anti-inflammatory medication is avoided for a defined window before and after. The rehabilitation programme runs alongside it, not instead of it.
Bone marrow aspirate concentrate
Reserved for high-grade injuries or injuries that have failed to improve with other treatments. It is not the first thing offered for a partial UCL tear, and it is not presented as a stronger version of PRP for every case.
Bracing
A hinged elbow brace limiting valgus load has a role during the early phase of a nonsurgical programme in selected athletes. It supports a rehabilitation plan; it does not substitute for one.
UCL repair with internal bracing
A surgical option distinct from full reconstruction, applicable to a specific subset — typically younger athletes with an avulsion-type tear off one end of an otherwise healthy ligament. The native ligament is repaired and augmented rather than replaced, and return to throwing is substantially faster than after reconstruction. It is not a universal alternative, and patient selection is the whole game.
UCL reconstruction (Tommy John surgery)
The right answer for complete tears in athletes who intend to keep throwing competitively, and for the partial tears that have genuinely failed a well-executed nonsurgical programme. A tendon graft replaces the ligament. Expect twelve to eighteen months before competitive pitching, with no throwing at all in the early months. Results in appropriately selected athletes are good, which is precisely why the selection matters.
How the choice actually gets made
Four inputs, in this order.
Is the tear complete? If it is, and the athlete intends to keep throwing competitively, the conversation is a surgical one. Nothing further on this list changes that.
If it is partial, where is it and how much does the joint open? A proximal partial tear with modest gapping under stress is the profile that does best without an operation. A distal tear with significant gapping is a harder case and should be discussed as one.
What has already been tried? An athlete who has never had a genuine throwing shutdown and a structured programme has not yet had nonsurgical treatment, whatever they have been told. An athlete who has completed one properly and is still failing has produced real information.
What is the timeline, and is it honest? A high school junior facing recruitment and a professional in the final year of a contract face genuinely different calculations. That conversation is worth having explicitly rather than letting an unspoken deadline drive a surgical decision.
Why a surgeon is the one saying this
Dr. Buford is a board-certified orthopedic surgeon. When the recommendation here is that an athlete does not need reconstruction, it comes from someone who has performed elbow surgery and knows exactly what the operation involves. And when a tear genuinely does require an operation, it is recognised and referred rather than treated indefinitely with injections by a clinic that has no other option to offer.
For parents of young throwers
If your son or daughter has been told they need Tommy John surgery, three things are worth knowing before you agree to a date.
First, ask whether the elbow has been examined with dynamic ultrasound under valgus stress, not only with MRI. An MRI report saying "UCL tear" does not answer whether the tear is partial or complete, where along the ligament it sits, or how much the joint opens under load — and those are the three things that determine whether surgery is necessary.
Second, be clear about what reconstruction costs in time. Twelve to eighteen months is not one season. For a high school athlete it can be two, and it lands in the years that recruitment decisions are made in.
Third, and least welcome: the largest risk factor for this injury in young throwers is fatigue, not pitch type and not velocity. Curveballs are not the villain they were made out to be. Throwing while tired is. The specific patterns that raise risk are pitching on multiple teams in overlapping seasons, throwing year-round with no genuine off-season, pitching through arm soreness, and back-to-back showcase events where every athlete is trying to peak the radar gun on consecutive days.
None of that is a criticism of a young athlete who is already injured. It is what determines whether the second injury happens after the first one is treated.
What recovery involves
After an orthobiologic injection, expect the elbow to be more sore for several days. Anti-inflammatory medication is avoided for a defined period. A short bracing period is used in some athletes.
Rehabilitation begins early and progresses deliberately: range of motion, then the scapular and rotator cuff work, then trunk and lower-body strength, then a formal interval throwing programme with distances and throw counts written down rather than estimated. Return to competitive throwing is measured in months. Nobody should be returning to a mound because a calendar date has arrived; return is earned by completing the programme without symptoms.
Progress is tracked objectively where it can be. Repeat ultrasound measurement of gapping under valgus stress, compared with the earlier reading and with the opposite elbow, gives a number rather than an impression — which matters over a recovery long enough that memory becomes unreliable.
Common questions
Can a UCL tear be treated without surgery?
In most cases, yes. We only refer patients for surgery if they have the most severe ligament tears. Most other ulnar collateral ligament injuries can be treated nonsurgically with orthobiologics in the office, which minimizes rehab time and eliminates surgical risk. The distinction that decides it is partial-thickness versus complete, and that is assessed with ultrasound under valgus stress during the visit rather than assumed from the diagnosis alone.
My son was told he needs Tommy John surgery. Should we get a second opinion?
Yes, and specifically one that includes a dynamic ultrasound examination of the elbow under valgus stress. A static MRI report describing a UCL tear does not tell you whether the ligament is partially or completely torn, where along its length the tear sits, or how much the joint actually opens under load. Those three things determine whether reconstruction is necessary, and two of them are best answered with the elbow moving rather than lying still in a scanner.
Does PRP work for a UCL tear?
For partial-thickness tears, the published experience is encouraging, and it is our primary orthobiologic approach for these injuries. High-dose platelet-rich plasma placed precisely into the torn portion of the ligament under ultrasound guidance, combined with a structured rehabilitation and return-to-throwing programme, allows a large share of throwers with partial tears to return without reconstruction. It is not a treatment for a complete tear in an athlete who intends to keep throwing competitively, and we do not present it as one.
I read a study saying PRP does not work for UCL tears. What about that?
You are probably thinking of Chauhan and colleagues in 2019, a matched cohort of 544 professional baseball players that found no improvement in return to play or ligament survivorship, and a longer delay before returning to throwing. It is the best-controlled study in this field and we do not dismiss it. The difficulty with the wider literature, and the reason the society position statements conclude that no consensus exists, is that it pools low-dose and high-dose PRP studies together and includes papers where no dose is reported at all. Our registry data and our review of the high-dose literature show that dose matters for this indication just as it does elsewhere in orthopedics. The question worth asking any clinic is not whether PRP works, but what dose, prepared how, placed where, and alongside what rehabilitation.
How long is recovery from Tommy John surgery compared with an injection?
Reconstruction typically means twelve to eighteen months before a pitcher is back to competitive throwing, and the first several months involve no throwing at all. A nonsurgical orthobiologic pathway is measured in months rather than in seasons, with a graduated return-to-throwing programme usually beginning several weeks after the injection. That difference is the single strongest argument for establishing whether a tear is genuinely complete before committing to an operation.
What is the difference between a partial and a complete UCL tear?
A partial tear means some intact ligament fibres still bridge the joint and still resist valgus load. A complete tear means none do. That difference is not visible from symptoms and is frequently not clear from an MRI report alone, because a static image cannot show how far the joint opens when the elbow is stressed. Dynamic ultrasound applies a valgus load and measures the gapping directly, in real time, and compares it with the opposite elbow.
Where the tear sits along the ligament — does that matter?
It matters a great deal and it is frequently overlooked. Tears at the proximal end, closer to the humerus, generally respond better to nonsurgical treatment than tears at the distal end near the ulnar attachment. Two athletes can carry the same grade of partial tear and face genuinely different odds depending on where along the ligament it sits, which is another reason the imaging needs to be read carefully rather than summarised as "UCL tear."
How do we keep this from happening again?
Fatigue is the single largest modifiable risk factor in throwing injuries, ahead of pitch type and ahead of velocity. Respecting pitch counts and required rest days, avoiding year-round throwing with no off-season, declining to pitch through arm soreness, and resisting the pull of back-to-back showcase events matter more than any change to mechanics. A young thrower who pitches on multiple teams in overlapping seasons is accumulating a load nobody is counting.
Who performs the injection?
Dr. Buford performs every injection himself, under direct ultrasound guidance. No physician assistant, nurse practitioner, or technician performs orthobiologic injections at Texas Orthobiologics. Call 877-777-8883 to arrange an evaluation.
